BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30369534)

  • 1. Transient Symptomatic Downregulation of Cortical Neurotransmitter Receptor Function Due to Cerebral Hyperperfusion after Arterial Bypass Surgery for a Patient with Ischemic Moyamoya Disease.
    Shimada Y; Kojima D; Yoshida J; Kobayashi M; Yoshida K; Fujiwara S; Ogasawara K
    Neurol Med Chir (Tokyo); 2018 Nov; 58(11):481-484. PubMed ID: 30369534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed development of cerebral atrophy after cerebral hyperperfusion following arterial bypass for adult patients with ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort.
    Katakura Y; Kubo Y; Dobashi K; Kimura K; Fujiwara S; Chida K; Kobayashi M; Yoshida K; Terasaki K; Ogasawara K
    Acta Neurochir (Wien); 2022 Apr; 164(4):1037-1045. PubMed ID: 35122551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease.
    Yanagihara W; Chida K; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Ogasawara K
    J Neurosurg; 2018 Dec; 131(6):1716-1724. PubMed ID: 30554180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
    Fujimura M; Shimizu H; Inoue T; Mugikura S; Saito A; Tominaga T
    Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral blood flow and metabolism of hyperperfusion after cerebral revascularization in patients with moyamoya disease.
    Kaku Y; Iihara K; Nakajima N; Kataoka H; Fukuda K; Masuoka J; Fukushima K; Iida H; Hashimoto N
    J Cereb Blood Flow Metab; 2012 Nov; 32(11):2066-75. PubMed ID: 22850406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion.
    Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of Intraoperative Graft Flow Predicts Radiological Hyperperfusion during Bypass Surgery in Patients with Moyamoya Disease.
    Nakamura A; Kawashima A; Nomura S; Kawamata T
    Cerebrovasc Dis Extra; 2020; 10(2):66-75. PubMed ID: 32726777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease.
    Hamano E; Kataoka H; Morita N; Maruyama D; Satow T; Iihara K; Takahashi JC
    J Neurosurg; 2017 Jan; 126(1):1-7. PubMed ID: 26894456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Moyamoya Disease: Region-Symptom Mapping and Estimating a Critical Threshold.
    Kazumata K; Uchino H; Tokairin K; Ito M; Shiga T; Osanai T; Kawabori M
    World Neurosurg; 2018 Jun; 114():e388-e395. PubMed ID: 29530706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic Development of Focal Cerebral Hyperperfusion After Revascularization Surgery for Adult Moyamoya Disease Associated With Autosomal Dominant Polycystic Kidney Disease.
    Tashiro R; Fujimura M; Endo H; Endo T; Niizuma K; Tominaga T
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3256-3260. PubMed ID: 30093201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossed cerebellar diaschisis as an indicator of severe cerebral hyperperfusion after direct bypass for moyamoya disease.
    Uchino H; Kazumata K; Ito M; Nakayama N; Kuroda S; Houkin K
    Neurosurg Rev; 2021 Feb; 44(1):599-605. PubMed ID: 32076897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient crossed cerebellar diaschisis due to cerebral hyperperfusion following surgical revascularization for moyamoya disease: case report.
    Hokari M; Kuroda S; Simoda Y; Uchino H; Hirata K; Shiga T; Nakayama N; Houkin K; Tamaki N
    Neurol Med Chir (Tokyo); 2012; 52(5):350-3. PubMed ID: 22688075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.
    Fujimura M; Inoue T; Shimizu H; Saito A; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2012; 33(5):436-45. PubMed ID: 22456617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease.
    Fujimura M; Kaneta T; Shimizu H; Tominaga T
    Childs Nerv Syst; 2007 Oct; 23(10):1195-8. PubMed ID: 17486352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative assessment of cortical perfusion by indocyanine green videoangiography in surgical revascularization for moyamoya disease.
    Uchino H; Kazumata K; Ito M; Nakayama N; Kuroda S; Houkin K
    Acta Neurochir (Wien); 2014 Sep; 156(9):1753-60. PubMed ID: 24973201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Cerebral Hyperperfusion after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis by Three-Dimensional-Time-of-Flight Magnetic Resonance Angiography in Adult Patients with Moyamoya Disease.
    Nishizawa T; Fujimura M; Katsuki M; Mugikura S; Tashiro R; Sato K; Tominaga T
    Cerebrovasc Dis; 2020; 49(4):396-403. PubMed ID: 32829323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Patients with Moyamoya Disease: Systematic Review and Meta-Analysis.
    Yu J; Zhang J; Li J; Zhang J; Chen J
    World Neurosurg; 2020 Mar; 135():357-366.e4. PubMed ID: 31759149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.
    Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC
    J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperatively reduced cerebrovascular contractile reactivity to hypocapnia by hyperventilation is associated with cerebral hyperperfusion syndrome after arterial bypass surgery for adult patients with cerebral misery perfusion due to ischemic moyamoya disease.
    Sato S; Kojima D; Shimada Y; Yoshida J; Fujimato K; Fujiwara S; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Tsutsui S; Miyoshi K; Ogasawara K
    J Cereb Blood Flow Metab; 2018 Jun; 38(6):1021-1031. PubMed ID: 29383984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
    Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.